Related Experiment Video

Updated: Apr 20, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

540

The molecular mechanisms and therapeutic potential of microRNA-7 in cancer

Dian-Na Gu1, Qian Huang, Ling Tian

  • 1Shanghai Jiao Tong University School of Medicine, Shanghai First People's Hospital, Experimental Research Center , Shanghai 201620 , PR China +86 21 37798755 ; +86 21 37798276 ; TL09168@hotmail.com.

Expert Opinion on Therapeutic Targets
|December 2, 2014
PubMed
Abstract

Insights

MicroRNA-7 (miR-7) acts as a tumor suppressor by regulating key cancer cell processes. Targeting miR-7 shows promise as a novel cancer therapy strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression, playing critical roles in cancer development.
  • MicroRNA-7 (miR-7) functions as a tumor suppressor, influencing cancer cell initiation, proliferation, migration, invasion, survival, and death.
  • miR-7 targets multiple oncogenic signaling pathways, highlighting its significance in cancer biology.

Purpose of the Study:

  • To review the biological roles of miR-7 in cancer.
  • To emphasize miR-7's regulation of oncogenic signaling pathways.
  • To discuss the potential of miR-7 as a therapeutic target for cancer.

Main Methods:

  • Literature review of existing research on miR-7 in cancer.
  • Analysis of miR-7's regulatory mechanisms in oncogenic pathways.
  • Evaluation of strategies and challenges for miR-7-based cancer therapeutics.

Main Results:

  • miR-7 demonstrates significant tumor-suppressive activity.
  • miR-7 effectively regulates critical oncogenic signaling pathways involved in cancer progression.
  • The understanding of miR-7's molecular mechanisms is advancing.

Conclusions:

  • Targeting miR-7 presents a promising therapeutic strategy for various cancers.
  • Advancements in miRNA therapeutics support the clinical potential of miR-7 targeting.
  • Further research into miR-7 regulatory networks will refine its therapeutic applications.
Keywords:
cancer cell signalingmicroRNAmicroRNA-7microRNA-based therapeuticspost-transcriptional regulation

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.1K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.2K
MicroRNAs01:22

MicroRNAs

12.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K